checkAd
    Startseite > Aktien > bluebird bio > Nachrichten
    bluebird bio Aktie
    0,9327
     
    USD
    +3,06 %
    +0,0277 USD
    Letzter Kurs 22:00:00 Nasdaq
    0,9325
     
    USD
    6.200 STK
    Geldkurs 22:02:00
    0,9354
     
    USD
    1.500 STK
    Briefkurs 22:02:00
    ISIN: US09609G1004 · WKN: A1W025 · SYM: BLUE · USA

    Neueste Nachrichten

    bluebird bio Appoints O. James Sterling as Chief Financial Officer
    29.05.24 · Business Wire (engl.) · bluebird bio
    The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against bluebird bio, Inc. (BLUE)
    24.05.24 · Business Wire (engl.) · bluebird bio
    BLUE INVESTOR ALERT: Kirby McInerney LLP Notifies bluebird bio, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit
    17.05.24 · Business Wire (engl.) · bluebird bio
    BLUE INVESTOR ALERT: Kirby McInerney LLP Notifies bluebird bio, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit
    14.05.24 · Business Wire (engl.) · bluebird bio
    bluebird bio Reports First Quarter 2024 Results and Highlights Operational Progress and 2024 Guidance
    09.05.24 · Business Wire (engl.) · bluebird bio
    bluebird bio Announces First Quarter 2024 Results Call Date and Upcoming Investor Events
    06.05.24 · Business Wire (engl.) · bluebird bio
    bluebird bio Announces Completion of First Cell Collection for LYFGENIA Gene Therapy
    06.05.24 · Business Wire (engl.) · bluebird bio
    bluebird bio Announces Receipt of Expected Notice from Nasdaq
    26.04.24 · Business Wire (engl.) · bluebird bio
    BLUE Shareholders with Significant Losses are Urged to Contact Robbins LLP to Discuss the bluebird bio, Inc. Class Action
    12.04.24 · Business Wire (engl.) · bluebird bio
    bluebird bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    11.04.24 · Business Wire (engl.) · bluebird bio
    BLUE INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that bluebird bio, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
    09.04.24 · Business Wire (engl.) · bluebird bio
    Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against bluebird bio, Inc. (BLUE)
    03.04.24 · Business Wire (engl.) · bluebird bio